Primary HCC patients with recurrence (34 of 60) and metastasis (23 of 60) exhibited higher levels of ONECUT2 than those without recurrence (26 of 60) or metastasis (37 of 60) (Fig. 1A). This evidence concerns the gene ONECUT2 and hepatocellular carcinoma.